Tradestie Institutional Equity Comparison Engine
IXHL vs ATYR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ATYR Overall Edge
ATYR Captures Institutional Edge (2โ1 Pillars ยท 2โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure while IXHL counters with relative strength in Valuation. Fundamentally, IXHL trades at 3.8x Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, IXHL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
IXHL
IXHL 3.8x vs ATYR N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs +0.0%
Momentum & Technical Winner
ATYR
1Y +397.2% vs +541.4% ยท 52W Pos 25% vs 60%
Options & Structure Winner
ATYR
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (36th %ile IV)
IXHL
NASDAQ
Incannex Healthcare Limited American Depositary Shares
Pharmaceutical Preparations
$1.75
-9.33% 1D
Market Cap
$24.7M
1M Return
-36.59%
1Y Return
+397.16%
Forward P/E
3.8x
Unified AI Score
52.3 / 100
HOLD
Tech 50.0
Fund 52.0
Flow 50.0
Mom 55.0
ATYR
NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap
$15.6M
1M Return
+2713.05%
1Y Return
+541.43%
Forward P/E
N/M
Unified AI Score
34.3 / 100
SELL
Tech 50.0
Fund 36.0
Flow 69.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IXHL +397.16%
ATYR +541.43%
Spread: +144.27 pp (ATYR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IXHL TTM Op. Margin: 0.0%
ATYR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IXHL vs ATYR. Trailing 12-month operating profitability (IXHL 0.0% vs ATYR 0.0%) and valuation multiples (IXHL 3.8x vs ATYR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IXHL | ATYR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $24.7M | $15.6M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 3.8x | N/M | Lower Multiple | IXHL |
| Forward P/E Ratio Valuation | 3.8x | N/M | Lower Multiple | IXHL |
| Revenue Growth (YoY) Growth | -100.0% | +0.0% | Higher Growth | ATYR |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -47.8% | -93.7% | Higher ROE | IXHL |
| 52-Week Range Position Momentum | 25% ($0โ$6) | 60% ($0โ$8) | Stronger Trend | ATYR |
| Beta / 30D Volatility Risk Regime | 1.38ฮฒ ยท 62% Vol | -9.57ฮฒ ยท 13806% Vol | Lower Realized Risk | IXHL |
| Unified Institutional Score Composite Signal | 52.3 / 100 (HOLD) | 34.3 / 100 (SELL) | Higher Composite | IXHL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IXHL vs ATYR Buy Guide
IXHL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ATYR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
36th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IXHL nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.